MACROGEN To Supply “X-Genome” Genome Analysis Service To Institute Of Psychiatry At King’s College London

SEOUL, South Korea--(BUSINESS WIRE)--Customized medicine & biotechnology company Macrogen Inc. (CEO HyungTae Kim, www.macrogen.com) announced that it has made an agreement to supply the company’s X-Genome (Xpressway to Genome) service, which is a large-scale human genome analysis service, to the Institute of Psychiatry at King’s College London (www.kcl.ac.uk, hereinafter KCL).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC